Brind.

Akebia Therapeutics (a company in the US) achieved profitability due to higher revenue on August 9, 2025.

1 report, 1 independent Updated Aug 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Akebia Therapeutics (a company in the US) achieved profitability due to higher revenue on August 9, 2025.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Simply Wall St.Akebia Therapeutics Second Quarter 2025 Earnings: EPS: US$0.001 (vs US$0.041 loss in 2Q 2024) Explore Akebia Therapeutics's Fair Values from the Community and select yours Revenue: US$62.5m (up 43%